{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:54:31Z","timestamp":1787867671489,"version":"build-2784847793"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Karolinska Institutet Funds"},{"name":"Swedish Heart Lung Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the association between venous thromboembolic (VTE) events and autoantibodies, following patients from RA diagnosis, measuring occurrence, levels and collective load of different autoantibodies against post-translational protein modifications, in particular recognizing citrullination (e.g. citrullinated fibrinogen) and RF by isotype.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cohort of 2814 patients with newly diagnosed RA were followed for incident VTE through register linkages. Sera from RA diagnosis were centrally analysed for antibodies to second generation cyclic citrullinated peptides (anti-CCP2), 20 anti-citrullinated protein antibody (ACPA) fine-specificities, antibodies to additional protein modifications (carbamylation and acetylation) and RF by isotype. Association between baseline serology status and future VTE was analysed using Cox regression adjusted for age, sex and calendar period of RA diagnosis, overall and stratified by anti-CCP2 and RF positivity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During a median 16\u2009years of follow-up, 213 first-ever VTE events were registered (5.0\/1000 person-years). IgG anti-CCP2 (present in 65% of cohort) associated with VTE (hazard ratio [HR]\u2009=\u20091.33, 95% CI: 1.00, 1.78), in a dose-response manner. The risk of VTE increased with number of ACPA fine-specificities. IgM RF, but no other RF isotypes, associated with VTE (HR\u2009=\u20091.38, 95% CI: 1.04, 1.82). The associations were independent from smoking and HLA-DRB1 shared epitope alleles. None of the carbamylated or acetylated antibody reactivities associated with VTE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Anti-CCP2, load of ACPA fine-specificities and IgM RF at RA diagnosis are associated with an increased risk of future VTE in RA. Antibodies to citrullinated fibrinogen did not differ substantially from other ACPA fine-specificities. Autoreactivity to other post-translational modifications was not associated with VTE risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac601","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T22:48:34Z","timestamp":1665787714000},"page":"2106-2112","source":"Crossref","is-referenced-by-count":10,"title":["The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3380-5342","authenticated-orcid":false,"given":"Helga","family":"Westerlind","sequence":"first","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet , Solna, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf","family":"Kastbom","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University , Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-3226","authenticated-orcid":false,"given":"Johan","family":"R\u00f6nnelid","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hansson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine (IMM), Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mathsson-Alm","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala, Sweden"},{"name":"Thermo Fisher Scientific , Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Serre","sequence":"additional","affiliation":[{"name":"Institut Toulousain des Maladies Infectieuses et Inflammatoires\u2014INFINITY, UMR 1291 Inserm, Universit\u00e9 Toulouse III , Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cornillet","sequence":"additional","affiliation":[{"name":"Institut Toulousain des Maladies Infectieuses et Inflammatoires\u2014INFINITY, UMR 1291 Inserm, Universit\u00e9 Toulouse III , Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[{"name":"Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Skriner","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Charit\u00e9 Campus Mitte, Rheumatologisches Forschungslabor AG Skriner , Berlin, Germany"},{"name":"German Rheumatism Research Center, Leibniz Institute , Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Bang","sequence":"additional","affiliation":[{"name":"ORGENTEC Diagnostika GmbH , Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Klareskog","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saedis","family":"Saevarsdottir","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet , Solna, Stockholm, Sweden"},{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland , Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-964X","authenticated-orcid":false,"given":"Karin","family":"Lundberg","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gr\u00f6nwall","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Askling","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet , Solna, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"2023060113225486200_keac601-B1","doi-asserted-by":"crossref","first-page":"e001392","DOI":"10.1136\/rmdopen-2020-001392","article-title":"Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study","volume":"6","author":"Galloway","year":"2020","journal-title":"RMD Open"},{"key":"2023060113225486200_keac601-B2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/2012.jama.11741","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization","volume":"308","author":"Holmqvist","year":"2012","journal-title":"JAMA"},{"key":"2023060113225486200_keac601-B3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/keaa262","article-title":"The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study","volume":"60","author":"Li","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023060113225486200_keac601-B4","doi-asserted-by":"crossref","first-page":"e001618","DOI":"10.1136\/rmdopen-2021-001618","article-title":"Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?","volume":"7","author":"Ozen","year":"2021","journal-title":"RMD Open"},{"key":"2023060113225486200_keac601-B5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/annrheumdis-2020-218419","article-title":"Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden","volume":"80","author":"Molander","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2023060113225486200_keac601-B6","doi-asserted-by":"crossref","first-page":"539.e7","DOI":"10.1016\/j.amjmed.2014.11.025","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs","volume":"128","author":"Kim","year":"2015","journal-title":"Am J Med"},{"key":"2023060113225486200_keac601-B7","doi-asserted-by":"crossref","first-page":"e001013","DOI":"10.1136\/rmdopen-2019-001013","article-title":"Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting","volume":"5","author":"Liang","year":"2019","journal-title":"RMD Open"},{"key":"2023060113225486200_keac601-B8","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/jth.15315","article-title":"Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis","volume":"19","author":"Evensen","year":"2021","journal-title":"J Thromb Haemost"},{"key":"2023060113225486200_keac601-B9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41584-021-00593-3","article-title":"Cardiovascular effects of approved drugs for rheumatoid arthritis","volume":"17","author":"Atzeni","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2023060113225486200_keac601-B10","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1136\/ard.2011.153536","article-title":"Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register","volume":"70","author":"Davies","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2023060113225486200_keac601-B11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/keab294","article-title":"Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study","volume":"61","author":"Desai","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023060113225486200_keac601-B12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.40798","article-title":"Comparative risk of venous thromboembolism in rheumatoid arthritis patients receiving tofacitinib versus those receiving tumor necrosis factor inhibitors: an observational cohort study","volume":"71","author":"Desai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2023060113225486200_keac601-B13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/BOR.0000000000000792","article-title":"Role of Janus Kinase inhibitors in rheumatoid arthritis treatment","volume":"33","author":"Reddy","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"2023060113225486200_keac601-B14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1373\/clinchem.2014.233296","article-title":"Increased rheumatoid factor and deep venous thrombosis: 2 cohort studies of 54628 individuals from the general population","volume":"61","author":"Meyer-Olesen","year":"2015","journal-title":"Clin Chem"},{"key":"2023060113225486200_keac601-B15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli","year":"2013","journal-title":"Dis Markers"},{"key":"2023060113225486200_keac601-B16","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.39267","article-title":"Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study","volume":"67","author":"Mantel","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2023060113225486200_keac601-B17","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.41381","article-title":"Anti-citrullinated protein antibody specificities, rheumatoid factor isotypes, and incident cardiovascular events in patients with rheumatoid arthritis","volume":"72","author":"Westerlind","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2023060113225486200_keac601-B18","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the \u03b1- and \u03b2-chains of fibrin","volume":"166","author":"Masson-Bessiere","year":"2001","journal-title":"J Immunol"},{"key":"2023060113225486200_keac601-B19","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood.2019004781","article-title":"A Mendelian randomization of \u03b3' and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke","volume":"136","author":"Maners","year":"2020","journal-title":"Blood"},{"key":"2023060113225486200_keac601-B20","doi-asserted-by":"crossref","first-page":"577523","DOI":"10.3389\/fimmu.2020.577523","article-title":"Detection of citrullinated fibrin in plasma clots of rheumatoid arthritis patients and its relation to altered structural clot properties, disease-related inflammation and prothrombotic tendency","volume":"11","author":"Bezuidenhout","year":"2020","journal-title":"Front Immunol"},{"key":"2023060113225486200_keac601-B21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1160\/TH16-09-0704","article-title":"Impact of fibrinogen carbamylation on fibrin clot formation and stability","volume":"117","author":"Binder","year":"2017","journal-title":"Thromb Haemost"},{"key":"2023060113225486200_keac601-B22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/metabo11050307","article-title":"Molecular dynamic simulations suggest that metabolite-induced post-translational modifications alter the behavior of the fibrinogen coiled-coil domain","volume":"11","author":"Sovova","year":"2021","journal-title":"Metabolites"},{"key":"2023060113225486200_keac601-B23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/CIRCRESAHA.121.319061","article-title":"Citrullinated fibrinogen renders clots mechanically less stable, but lysis-resistant","volume":"129","author":"Varju","year":"2021","journal-title":"Circ Res"},{"key":"2023060113225486200_keac601-B24","doi-asserted-by":"crossref","first-page":"685312","DOI":"10.3389\/fimmu.2021.685312","article-title":"Autoantibodies in rheumatoid arthritis \u2013 laboratory and clinical perspectives","volume":"12","author":"Ronnelid","year":"2021","journal-title":"Front Immunol"},{"key":"2023060113225486200_keac601-B25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/03009740903501634","article-title":"Non-participation in EIRA: a population-based case-control study of rheumatoid arthritis","volume":"39","author":"Bengtsson","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"2023060113225486200_keac601-B26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/ard.62.9.835","article-title":"Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases","volume":"62","author":"Stolt","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2023060113225486200_keac601-B27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2017-211782","article-title":"Anticitrullinated protein\/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants","volume":"77","author":"Ronnelid","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023060113225486200_keac601-B28","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","article-title":"A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis","volume":"50","author":"Padyukov","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023060113225486200_keac601-B29","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/art.39170","article-title":"Associations with smoking and shared epitope differ between IgA- and IgG-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis","volume":"67","author":"Svard","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2023060113225486200_keac601-B30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-020-02191-2","article-title":"Presence of autoantibodies in \u201cseronegative\u201d rheumatoid arthritis associates with classical risk factors and high disease activity","volume":"22","author":"Reed","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2023060113225486200_keac601-B31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2016-209297","article-title":"Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs","volume":"76","author":"Figueiredo","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023060113225486200_keac601-B32","doi-asserted-by":"crossref","first-page":"627986","DOI":"10.3389\/fimmu.2021.627986","article-title":"A comprehensive evaluation of the relationship between different IgG and IgA anti-modified protein autoantibodies in rheumatoid arthritis","volume":"12","author":"Gronwall","year":"2021","journal-title":"Front Immunol"},{"key":"2023060113225486200_keac601-B33","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023060113225486200_keac601-B34","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/annrheumdis-2013-205109","article-title":"Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies","volume":"73","author":"Jiang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2023060113225486200_keac601-B35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.55563\/clinexprheumatol\/4bcmdb","article-title":"Rheumatoid arthritis autoantibodies and their association with age and sex","volume":"39","author":"Pertsinidou","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2023060113225486200_keac601-B36","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200526000","article-title":"Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis","volume":"35","author":"Burkhardt","year":"2005","journal-title":"Eur J Immunol"},{"key":"2023060113225486200_keac601-B37","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.38383","article-title":"Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagen","volume":"66","author":"Haag","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2023060113225486200_keac601-B38","doi-asserted-by":"crossref","first-page":"804822","DOI":"10.3389\/fimmu.2022.804822","article-title":"Antibodies to a citrullinated Porphyromonas gingivalis epitope are increased in early rheumatoid arthritis, and can be produced by gingival tissue B cells: implications for a bacterial origin in RA etiology","volume":"13","author":"Sherina","year":"2022","journal-title":"Front Immunol"},{"key":"2023060113225486200_keac601-B39","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1136\/annrheumdis-2015-208579","article-title":"Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts","volume":"75","author":"Ajeganova","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023060113225486200_keac601-B40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13075-016-1001-6","article-title":"Antibodies to carbamylated \u03b1-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies","volume":"18","author":"Reed","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2023060113225486200_keac601-B41","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.41385","article-title":"Different hierarchies of anti-modified protein autoantibody reactivities in rheumatoid arthritis","volume":"72","author":"Sahlstrom","year":"2020","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac601\/46799541\/keac601.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/6\/2106\/50500555\/keac601.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/6\/2106\/50500555\/keac601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T13:27:41Z","timestamp":1685626061000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/6\/2106\/6762856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,10,18]]},"published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac601","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2022,10,18]]}}}